Travere Therapeutics Announces Pricing of Public Offering of Common Stock
Portfolio Pulse from
Travere Therapeutics has announced the pricing of a public offering of 7,812,500 shares of its common stock at $16.00 per share, aiming to raise $125 million. The offering is expected to close on November 12, 2024.
November 08, 2024 | 2:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Travere Therapeutics is conducting a public offering of 7,812,500 shares at $16 per share, expected to raise $125 million. This could lead to short-term stock price volatility.
The public offering will increase the number of shares available in the market, which can lead to a decrease in the stock price due to dilution. The offering price of $16 may also set a short-term price ceiling.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100